Complement in the Pathogenesis of Autoimmune Arthritis
补体在自身免疫性关节炎发病机制中的作用
基本信息
- 批准号:9044728
- 负责人:
- 金额:$ 34.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-03 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAlternative Complement PathwayAnaphylatoxinsAnimal ModelAntibodiesAntibody ActivationAntigen-Antibody ComplexAntigensArthritisAutoantibodiesAutoimmune DiseasesBasic ScienceBindingCartilageChronicCleaved cellCollagenComplementComplement 3aComplement 5aComplement ActivationComplement Factor DComplement Factor HComplement Membrane Attack ComplexComplexDepositionDevelopmentDiseaseDistalEffector CellExhibitsFibroblastsFundingGeneticHealthHumanImmuneIn VitroInflammatoryInflammatory ArthritisInjuryJointsKnowledgeLectinMannose Binding LectinMannose-Binding LectinsMediatingModelingMolecularMusNatural ImmunityOutcomePathogenesisPathway interactionsPatientsPhasePlayPopulationProcessProtein BiosynthesisProtein FamilyProteinsRecombinant ProteinsRegulationRheumatoid ArthritisRoleSerine ProteaseSignal TransductionStressSynovial CellSynovitisTimeTissue FixationTissuesWorkautoimmune arthritisbasebone erosioncollagen antibody induced arthritiscomplement pathwaycomplement systemcostdisabilitygenetic regulatory proteinhuman diseaseimprovedin vivoinhibitor/antagonistinjuredinsightjoint injurynew therapeutic targetnovelpathogenreceptorresearch studytool
项目摘要
DESCRIPTION (provided by applicant): The complement system is a major component of innate immunity and plays a central role in the pro-inflammatory mechanisms that drive the pathogenesis of human rheumatoid arthritis (RA). In this process, inappropriate complement activation that is directed to self-tissues drives cellular influx, synovial inflammation and bone erosions. Recent findings suggest that this pathogenic process is likely to be especially important in the early phases of disease when circulating autoantibodies initially react with antigens which develop and are displayed in the joint. We have used an animal model of RA designated collagen antibody-induced arthritis (CAIA) to understand the molecular basis for these injurious roles of complement. One major focus of the proposed studies will be on how complement is activated within the joint by injured tissues through the engagement of the lectin pathway, which we recently unexpectedly found to play a major role in CAIA. Once activated, the lectin pathway leads to pathogenic engagement of the alternative pathway amplification loop. We will also determine whether factor H (FH), a soluble protein that we have shown plays an essential role in controlling complement activation on the acellular cartilage and stressed fibroblast-like synovial (FLS) cells, is itself the target of "de-regulatory" proteins from the facor H related (FHR) protein family which modulate its function. Finally, we have made the surprising finding that distal complement effector pathways initiated by anaphylatoxin C5a and C3a receptor engagement amplifies anti-collagen antibody deposition and proximal complement C3 activation, resulting in greatly increased joint damage. We intend to characterize the molecular mechanisms by which this distal amplification process occurs and determine what effector cells and danger signals mediate this effect. As a major focus of this effort, we have identified and wil explore a new injury mechanism through the engagement of hard-wired pathogenic natural antibodies that recognize injury- associated neoepitopes as danger signals and further increase complement activation. Through these efforts we hope to identify novel means by which we can beneficially modulate complement in a therapeutically efficacious manner.
描述(由适用提供):完成系统是先天免疫的主要组成部分,并且在促进人类类风湿关节炎(RA)发病机理的促炎机制中起着核心作用。在此过程中,针对自我组织的不当完成激活驱动细胞影响,滑膜感染和骨侵蚀。最近的发现表明,当循环自身抗体与最初与抗原发生反应的抗原时,这种致病过程在疾病的早期阶段尤为重要。我们已经使用了RA设计的胶原蛋白抗体诱导的关节炎(CAIA)的动物模型来了解这些受伤的完成作用的分子基础。拟议的研究的一个主要重点将是通过讲座途径通过受伤组织在关节内如何激活完成的重点,我们最近意外地发现这在凯亚(CAIA)中起着重要作用。一旦激活,讲座途径就会导致替代途径放大环的致病性参与。我们还将确定因子H(FH)是一种固体蛋白,我们在控制细胞软骨上的完成激活中表现出至关重要的作用,而应力的成纤维细胞样滑膜(FLS)细胞本身是从Faceer H相关(FHR)蛋白(FHR)蛋白(调节其功能)的“去调节性”蛋白的靶标。最后,我们提出了一个令人惊讶的发现,远端补体效应子途径由过敏毒素C5A和C3A受体参与放大器抗胶原抗体沉积和近端完成C3激活,从而大大增加关节损伤。我们打算表征这种远端放大器过程发生的分子机制,并确定效应细胞和危险信号介导这种效果。作为这项工作的主要重点,我们通过参与硬连线的致病天然抗体来探索并探索一种新的伤害机制,这些抗体识别损伤与造成的Neoeppitopes是危险信号并进一步增加完成激活。通过这些努力,我们希望确定我们可以以治疗效率进行有益地调节完成的新颖手段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vernon Michael Holers其他文献
Vernon Michael Holers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vernon Michael Holers', 18)}}的其他基金
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis
粘膜免疫生物学和风湿病发病机制中心
- 批准号:
10277290 - 财政年份:2021
- 资助金额:
$ 34.21万 - 项目类别:
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis Administrative Core
粘膜免疫生物学和风湿性疾病发病机制中心行政核心
- 批准号:
10277291 - 财政年份:2021
- 资助金额:
$ 34.21万 - 项目类别:
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis
粘膜免疫生物学和风湿病发病机制中心
- 批准号:
10700077 - 财政年份:2021
- 资助金额:
$ 34.21万 - 项目类别:
Center for Mucosal Immunobiology and Rheumatic Disease Pathogenesis Administrative Core
粘膜免疫生物学和风湿性疾病发病机制中心行政核心
- 批准号:
10700078 - 财政年份:2021
- 资助金额:
$ 34.21万 - 项目类别:
Novel Therapeutic Approaches for Lupus Nephritis
狼疮性肾炎的新治疗方法
- 批准号:
10190935 - 财政年份:2020
- 资助金额:
$ 34.21万 - 项目类别:
Novel Therapeutic Approaches for Lupus Nephritis
狼疮性肾炎的新治疗方法
- 批准号:
10615186 - 财政年份:2020
- 资助金额:
$ 34.21万 - 项目类别:
Novel Therapeutic Approaches for Lupus Nephritis
狼疮性肾炎的新治疗方法
- 批准号:
10403435 - 财政年份:2020
- 资助金额:
$ 34.21万 - 项目类别:
Complement in the Pathogenesis of Autoimmune Arthritis
补体在自身免疫性关节炎发病机制中的作用
- 批准号:
10255878 - 财政年份:2020
- 资助金额:
$ 34.21万 - 项目类别:
Novel Therapeutic Approaches for Lupus Nephritis
狼疮性肾炎的新治疗方法
- 批准号:
10033331 - 财政年份:2020
- 资助金额:
$ 34.21万 - 项目类别:
Evolving Adaptive and Effector Mechanisms from Pre-RA through Established Disease
从 RA 前期到已确定疾病的适应性和效应机制的演变
- 批准号:
9323969 - 财政年份:2014
- 资助金额:
$ 34.21万 - 项目类别:
相似国自然基金
海洋缺氧对持久性有机污染物入海后降解行为的影响
- 批准号:42377396
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
氮磷的可获得性对拟柱孢藻水华毒性的影响和调控机制
- 批准号:32371616
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
还原条件下铜基催化剂表面供-受电子作用表征及其对CO2电催化反应的影响
- 批准号:22379027
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CCT2分泌与内吞的机制及其对毒性蛋白聚集体传递的影响
- 批准号:32300624
- 批准年份:2023
- 资助金额:10 万元
- 项目类别:青年科学基金项目
在轨扰动影响下空间燃料电池系统的流动沸腾传质机理与抗扰控制研究
- 批准号:52377215
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
BIN1-interactome in Alzheimer's disease pathophysiology
BIN1-相互作用组在阿尔茨海默病病理生理学中的作用
- 批准号:
10677190 - 财政年份:2023
- 资助金额:
$ 34.21万 - 项目类别:
Complementopathies: biology, biomarkers, and targets
补体病:生物学、生物标志物和靶标
- 批准号:
10687425 - 财政年份:2022
- 资助金额:
$ 34.21万 - 项目类别:
TargetAD: A systems multi-omics approach to drug repositioning in Alzheimer's disease
TargetAD:一种用于阿尔茨海默病药物重新定位的系统多组学方法
- 批准号:
10299231 - 财政年份:2021
- 资助金额:
$ 34.21万 - 项目类别:
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10448505 - 财政年份:2021
- 资助金额:
$ 34.21万 - 项目类别:
Large-scale CRISPR screening of essential calcium-related genes in the human parasite Tr. cruzi
大规模 CRISPR 筛选人类寄生虫 Tr 中必需的钙相关基因。
- 批准号:
10447846 - 财政年份:2021
- 资助金额:
$ 34.21万 - 项目类别: